Serum and Urinary Metabolomic Analysis in Patients with Diabetic Nephropathy
WANG Xu-fang,LI Meng-jie,GE Yong-chun,QIN Wei-song,A Ji-ye,HOU Jin-hua,XIE Hong-lang,WANG Guang-ji,LIU Zhi-hong
DOI: https://doi.org/10.3969/j.issn.1006-298x.2012.03.001
2012-01-01
Abstract:Objective:To investigate the metabolomic profile in serum and urine of patients with DN at different stages,and find out biomarkers for early diagnosis and prognosis of DN. Methodology:Ninety male patients diagnosed as type 2 diabetic mellitus (T2DM) were enrolled this study.They were divided into 3 groups (normoalbuminuria,n=30,microalbuminuria,n=30,and proteinuria,n=30). Twenty-five health controls were included. Serum and urine metabolites were analyzed using gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS). Results:Distinct metabolomic differences were observed between different stages of DN. All the three groups of patients showed clear dysfunction of glycolysis and tricarboxylic acid cycle. Activation of protein kinase C pathway and hexosamine biosythesis pathway were also demonstrated. The levels of serum branched-chain amino acids were increased in the diseased group.The levels of serum non-essential fatty acid were elevated,while L-cartinine and acyl CoA were decreased,which indicated the dysfunction of β-oxidation of fatty acids. The palmitic acid in the serum,as well as PC (P-19∶1(12Z)/0∶1) and dodecanedioic acid in the urine might be candidate biomarker for early diagnosis of DN. DecanoylL-carnitine,PC(9∶0/0∶0) and Dg (17∶2(9Z,2Z)/20∶3 (8Z,11Z,14Z)/0∶0) in the serum,as well as uridine diphosphate and lysoPC (16∶0) might be candidate biomarkers for prognosis of DN. Conclusion:Our study demonstrated the changes of metabolic profile in different stages of DN,and provided candidate biomarkers for early diagnosis and prognosis.
What problem does this paper attempt to address?